- Report
- October 2023
- 90 Pages
India
From €3185EUR$3,500USD£2,731GBP
- Report
- April 2023
- 112 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- October 2022
- 110 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- January 2021
- 245 Pages
Global
From €3276EUR$3,600USD£2,809GBP
- Report
- October 2023
- 180 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- March 2022
- 157 Pages
Global
From €3276EUR$3,600USD£2,809GBP
- Report
- January 2024
- 255 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- January 2024
- 100 Pages
Africa
From €1820EUR$2,000USD£1,560GBP
- Report
- January 2024
- 80 Pages
Brazil
From €1365EUR$1,500USD£1,170GBP
- Report
- January 2024
- 80 Pages
China
From €1365EUR$1,500USD£1,170GBP
- Report
- January 2024
- 80 Pages
France
From €1365EUR$1,500USD£1,170GBP
- Report
- January 2024
- 80 Pages
Germany
From €1365EUR$1,500USD£1,170GBP
- Report
- January 2024
- 80 Pages
India
From €1365EUR$1,500USD£1,170GBP
- Report
- January 2024
- 80 Pages
Ireland
From €1365EUR$1,500USD£1,170GBP
- Report
- January 2024
- 80 Pages
Japan
From €1365EUR$1,500USD£1,170GBP
- Report
- January 2024
- 80 Pages
Russia
From €1365EUR$1,500USD£1,170GBP
- Report
- January 2024
- 80 Pages
Saudi Arabia
From €1365EUR$1,500USD£1,170GBP
- Report
- January 2024
- 80 Pages
South Korea
From €1365EUR$1,500USD£1,170GBP
- Report
- January 2024
- 80 Pages
United States
From €1365EUR$1,500USD£1,170GBP
- Report
- January 2024
- 80 Pages
Vietnam
From €1365EUR$1,500USD£1,170GBP

Uveitis is a medical condition that affects the uvea, the middle layer of the eye. It is characterized by inflammation of the uvea, which can lead to vision loss and other complications. In the context of optical, uveitis is a major cause of vision loss and can be treated with a variety of treatments, including topical and systemic medications, laser treatments, and surgery.
Uveitis is a growing market in the optical industry, as it is a common cause of vision loss and can be treated with a variety of treatments. Companies in the uveitis market include Bausch + Lomb, Novartis, Allergan, and Santen Pharmaceuticals. These companies offer a range of treatments for uveitis, including topical and systemic medications, laser treatments, and surgery. Show Less Read more